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ABSTRACT: To establish a highly efficient method of ex vivo expansion of 
hematopoietic cells (HCs), three-dimensional (3D) cocultures of HCs and stromal cell 
lines were performed using porous polymer scaffolds. Hematopoietic cells derived 
from mouse fetal livers were expanded by two successive cultures without the use of 
exogenous cytokines, i.e., 3D cultures of stromal cells (DAS 104-8 cell line) to form 
stromal layers within the scaffolds and, subsequently, by cocultures of the HCs on the 
stromal cell layers for two weeks. To expand the HCs more conveniently, in some 
experiments the stromal layers formed within the scaffolds were frozen (3D freezing) 
before the cocultures, then stored, and applied to the cocultures after thawing. When 
the HCs were cocultured on the stromal layers of the DAS 104-8 cells, primitive HCs 
(c-kit+ and CD34+ cells) were expanded several-fold during the cocultures. In contrast, 
the expansion of these primitive HCs was remarkably enhanced in the cocultures 
using the 3D frozen-thawed DAS 104-8 stromal layers (c-kit+ cells > 15-fold and 
CD34+ cells > 30-fold), and these expansions were significantly higher than those 
without the 3D freezing. The expansions enhanced by cocultures on the 3D 
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frozen-thawed stromal layers were also observed in the cocultures with another 
stromal cell line (DAS 104-4). Because 3D frozen-thawed stromal cell lines are easy 
to handle, 3D coculture of HCs on frozen-thawed stromal cell lines may be an 
effective and convenient method for expanding primitive HCs.  
Key words: hematopoietic stem cell; hematopoietic progenitor cell; stromal cell; 
tissue engineering; three-dimensional culture; cryopreservation
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Introduction 
To treat patients with potentially fatal hematologic diseases such as acute leukemia, 
hematopoietic stem cell (HSC) transplantation is the most effective life-saving 
therapy. However, widespread use of HSC transplantation has been prevented by the 
difficulties in finding major histocompatibility complex-matched donors, and 
establishment of effective methods of ex vivo expansion of hematopoietic 
stem/progenitor cells (HSPCs) obtained from bone marrow or human umbilical cord 
blood (hUCB) is well recognized as a promising approach for solving this serious 
issue [1,2].  
     For more than three decades, many investigations of ex vivo expansion of 
hematopoietic cells (HCs) sought to mimic the hematopoietic microenvironment of 
bone marrow, e.g., cocultures of HCs and stromal cells and addition of the soluble 
components secreted by these cells [1,3-7]. With respect to cocultures, HCs are 
generally seeded on stromal layers that are initially formed on culture dishes, and 
consequently, successive cultures to form a stromal layer and then expand HSPCs are 
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needed [3,6,7]. Although the effectiveness of these cocultures in expansion of HSPCs 
has been clearly demonstrated, the long culture period required for the successive 
cultures is a serious disadvantage of these methods. Moreover, the research studies on 
expansion of HCs were mostly performed with two-dimensional (2D) monolayer 
cultures, and little attention has been paid to the effects of three-dimensional (3D) 
cultures that also mimic the microenvironment of bone marrow [8-11].  
     From the viewpoint of tissue engineering, establishment of effective culture 
methods that allows safe, large-scale expansion of HSPCs is required for their clinical 
application, and 3D cultures of HCs seem to be essential for meeting this requirement. 
In our previous studies, HCs obtained from mouse bone marrow cells (BMCs) were 
cocultured with bone marrow-derived stromal cells (BMSCs) under 3D conditions 
using porous polymer scaffolds [12-14]. In those culture experiments, the stromal cell 
layers formed within the 3D scaffold were frozen (3D freezing) and then applied to 
the cocultures of HCs after thawing in order to shorten the culture period practically 
by separating the culture for formation of the stromal layers from that for expansion 
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of HSPCs [14]. Interestingly, we found that a greater expansion of HCs was achieved 
in the cultures using the stromal cells with 3D freezing than in those without freezing. 
Therefore, 3D cocultures with 3D frozen-thawed stromal cells seemed to be an 
attractive method for expansion of HCs with high efficiency.  
     As a next step toward the application of this coculture method to HSC 
transplantation, use of stromal cell lines instead of BMSCs and the choice of such cell 
lines suitable for HC expansion should be considered because stromal cell lines are 
easier to harvest and have greater homogeneity than BMSCs. In the present study, 
two stromal cell lines derived from the aorta-gonad-mesonephros (AGM) region were 
applied for the 3D cocultures, and HCs in the fetal liver cells (FLCs), which contain 
more primitive HCs than does bone marrow, were expanded in these cocultures as a 
model of HC expansion in hUCB [15]. The expansion of the HCs in these cultures 
was compared with that in the cocultures with BMSCs. The effects on the expansion 
of HCs of the 3D frozen-thawed stromal cell lines as well as those of the periods of 
stromal cell cultures prior to the cocultures were also investigated.  
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Methods 
Cells and culture media 
Two types of stromal cell lines, DAS 104-8 and DAS 104-4, both established from 
the AGM region of C57BL/6 mouse embryos (embryonic day [ED] 11), were 
provided by Professor Ohneda of the University of Tsukuba [16]. As in our previous 
studies [12-14], the BMCs used as the source of stromal cells in the control 
experiments were isolated from the tibiae and femora of 6-week-old C57BL/6N male 
mice (Charles River Laboratories Japan, Yokohama, Kanagawa, Japan). As a source 
of HCs, FLCs were harvested from C57BL/6NCrSlc mice (Japan SLC, Hamamatsu, 
Shizuoka, Japan) on ED 14 according to a previously reported method [17]. All mice 
were treated according to the University of Tsukuba Animal Experiment Committee 
Guidelines for the Care and Use of Laboratory Animals.  
     In the culture experiments using DAS 104-8 or DAS 104-4 cells, i.e., cultures 
of these stromal cell lines for formation of the stromal layer and subsequent 
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cocultures with FLCs, high-glucose Dulbecco's modified Eagle's medium (Gibco®, 
Life Technologies, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS; 
MP Biomedicals, Tokyo, Japan), 10-4 M MEM nonessential amino acids (Gibco), 2 x 
10-3 M L-glutamine (Gibco), 10-4 M β-mercaptoethanol (Wako Pure Chemical 
Industries, Osaka, Japan), and 0.5% penicillin-streptomycin (Gibco) (HAVA 
medium) was used [16]. In the control experiments using BMSCs, BMSCs and FLCs 
reinoculated on the layers of the BMSCs were cultured in minimum essential 
medium-alpha (Gibco) containing 10% FBS, 10% horse serum (Stem Cell 
Technologies, Veritas Corporation, Tokyo, Japan), 10-7 M dexamethasone 
(Sigma-Aldrich Japan, Tokyo, Japan), 5 x 10-5 M 2-mercaptoethanol, and 0.2% 
antibiotics (Gibco) (αMEM), as in our previous studies [13,14].  
 
3D scaffold, cell seeding, and 3D freezing of stromal cells 
In all culture experiments, a highly porous polyvinyl formal (PVF) resin (Aion, 
Osaka, Japan) was used as the 3D scaffold [12-14,18,19]. Resin with a mean pore 
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size of 130 µm was cut into cubes (2 x 2 x 2 mm3), sterilized in an autoclave, and 
coated with type I collagen (Koken, Tokyo, Japan) [18].  
     At the initiation of the stromal cell cultures and cocultures of FLCs on the 
stromal layers, cells were seeded into the scaffolds by the centrifugal cell 
immobilization (CCI) method, as previously reported [20]. Briefly, a centrifuge bottle 
containing 100 PVF cubes and cell aliquots suspended in culture medium was 
centrifuged six times to entrap the cells within the scaffolds. 
     For the coculture experiments using 3D frozen-thawed stromal cells, the cubic 
scaffolds containing stromal layers formed by the stromal cell cultures were frozen to 
-80oC at -1oC/min in culture medium containing 10% dimethyl sulfoxide [14,21]. The 
frozen scaffolds were stored in liquid nitrogen and then thawed in a 37oC water bath 
just before the cocultures.  
 
Culture experiments 
To expand the HCs present in the FLCs, stromal cells (DAS 104-8 or DAS 104-4, and 
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BMSCs as controls) were first cultured within the 3D scaffolds to form stromal layers, 
and successive cocultures of FLCs on these stromal layers were then performed 
[12-14]. The conditions of the stromal cell cultures, including the stromal cells used, 
culture media, duration of the cultures, and presence or absence of 3D freezing, are 
summarized in Table 1.  
     In the stromal cell cultures, the cells were seeded into cubic scaffolds at a 
density of 1 x 107 cells/cm3 of scaffold. Next, 10 cubic scaffolds containing the cells 
were placed in a 35-mm culture dish, followed by an addition of 2 mL of culture 
medium. The cells were cultured for 3, 7, or 10 days (DAS 104-8), for 7 days (DAS 
104-4) or for 14 days (BMSCs) prior to the cocultures (Table 1) [14]. At the 
beginning of the cocultures, freshly isolated FLCs at a density of 5 x 107 cells/cm3 of 
scaffold were reinoculated by means of the CCI method into the scaffolds containing 
the stromal layers, and these cells were cocultured for 2 weeks under similar 
conditions to those used for the stromal cell cultures.  
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Cell counting, FACS analysis, and SEM observation 
The number of total cells in the cultures using stromal cell lines (DAS 104-8 or DAS 
104-4) was estimated by measuring the amount of DNA in the cells immobilized 
within the scaffolds using Hoechst 33342 solution [19]. In the control cultures using 
BMSCs, the total cell numbers were measured by a colorimetric MTT assay using 
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) [22], as 
previously reported [13,14,18].  
     To examine the percentages of erythroid cells, B cells, hematopoietic 
progenitor cells (HPCs), and HSPCs among the cultured cells, fluorescence-activated 
cell sorter (FACS) analysis was performed with a BD FACSCalibur (Becton 
Dickinson, Franklin Lakes, NJ) [13,14]. As respective specific markers for these cells, 
anti-Ter119, anti-B220, anti-c-kit, and anti-CD34 monoclonal antibodies (all from 
PharMingen, San Diego, CA) were used. The numbers of specific-marker-positive 
cells were calculated from the numbers of total cells and the percentages of positive 
cells. 
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     The morphology of the cultured cells within the scaffolds was observed by 
scanning electron microscopy (SEM; JSM-6320F; JEOL, Tokyo, Japan) [23].  
 
Statistical analysis 
Data were expressed as the mean ± standard deviation (SD). Statistical analysis was 
carried out using the t test, and significance was set at p < 0.05. 
 
Results 
Growth of stromal cell lines 
For formation of the stromal layers, both stromal cell lines proliferated well within 
the scaffolds (Fig. 1), and DAS 104-4 showed a higher growth rate than did DAS 
104-8. To expand HCs, these cells cultured for 3, 7, and 10 days were applied to the 
coculture experiments just after the stromal cell cultures were completed or after the 
3D freezing (Table 1).  
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Expansion of HCs in cocultures with DAS 104-8 cells 
The changes in the densities of total cells and each HC type over time in the 
cocultures of FLCs with DAS 104-8 cells as well as in the control cultures with 
BMSCs are shown in Figure 2. No marked increases in the total cell densities from 
day 1 to day 14 were observed, probably owing to the high cell densities in these 
cocultures on day 1 (Fig. 2A). With respect to the expansion of HCs, the numbers of 
B cells, HPCs, and HSPCs increased in most of the cocultures (Fig. 2C-E). In 
particular, primitive HCs (HPCs and HSPCs) were well expanded in the cocultures 
with DAS 104-8 cells (DAS8/3, DAS8/7, DAS8/10) irrespective of the culture 
periods of the stromal cells (Fig. 2D, E), and these expansions were comparable to 
those of the cocultures with BMSCs (BM/14).  
     The percentages of HCs in these cocultures are summarized in Table 2. 
Cocultures in which significant changes in the percentages of the HCs were measured 
from day 1 to day 14 largely corresponded to those in which the numbers of these 
cells significantly changed (Fig. 2B-E). In the cocultures with DAS 104-8 cells, the 
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percentages of HPCs and HSPCs on day 14 were comparable to or slightly higher 
than those in the BM/14 coculture. From these results, it was revealed that DAS 
104-8 cells have the ability to support ex vivo expansion of primitive HCs similar to 
that of BMSCs.  
 
Expansion of HCs in cocultures with frozen-thawed DAS 104-8 cells 
In the cocultures of FLCs on the frozen-thawed DAS 104-8 stromal layers (Fig. 3), 
total cell densities gradually increased with time in the cocultures using DAS 104-8 
cells (fDAS8/7, fDAS8/10), whereas cell densities on day 14 in the control 
experiments (fBM/14) were almost the same as those on day 1 (Fig. 3A). With 
respect to the primitive HCs, the densities of HPCs and HSPCs significantly 
increased in the cocultures with DAS 104-8 cells (fDAS8/7, fDAS8/10) (Fig. 3D, E). 
These increases were far higher than those in the fBM/14 coculture and were also 
higher than those in the cocultures without the 3D freezing (Fig. 2D, E). Between the 
fDAS8/7 and fDAS8/10 cocultures, negligible differences in the expansion of each 
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HC type were detected.  
     As shown in Table 3, the percentages of the HPCs and HSPCs significantly 
increased with time in the fDAS8/7 and fDAS8/10 cocultures, which differed from 
the fBM/14 coculture. Notably, the percentages of the primitive HCs on day 14 in 
most cocultures with DAS 104-8 cells (fDAS8/7, fDAS8/10) were significantly 
higher than those in the fBM/14 coculture, although the percentages on day 1 were 
lower than in the fBM/14 coculture. These results revealed that the effects of 3D 
freezing of stromal cells on the expansion of primitive HCs differ considerably 
according to the stromal cells used.  
 
Expansion of HCs in cocultures with DAS 104-4 cells 
To examine the applicability of 3D freezing to other stromal cell lines, DAS 104-4 
cells cultured for 7 days were used for the coculture experiments, in addition to DAS 
104-8 cells. As shown in Figure 4, no significant changes in the densities of the HCs 
were detected in the cocultures without 3D freezing (DAS4/7) (Fig. 4B-E). In 
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contrast, the densities of B cells, HPCs, and HSPCs significantly increased in the 
cocultures with 3D freezing (fDAS4/7) (Fig. 4C-E), and the density of HPCs on day 
14 was significantly higher in the fDAS4/7 coculture than in the DAS4/7 coculture 
(Fig. 4D). From the percentages of HCs in these cocultures (Table 4), significant 
increases in the percentages of the primitive HCs from day 1 to day 14 in the 
fDAS4/7 coculture contributed to the increases in the numbers of these cells (Fig. 4D, 
E).  
 
Comparison of HC expansion in coculture experiments 
The expansions of HCs in all coculture experiments are summarized in Figure 5. In 
most cultures, the HCs other than erythroid cells were expanded (cell expansion > 1) 
during the 2-week coculture experiments. In the cocultures with 3D frozen-thawed 
DAS 104-8 cells, except those of HPCs in the fDAS8/10 coculture, significantly 
higher expansions of these HCs than of those without 3D freezing were obtained (Fig. 
5B-D). High expansions of primitive HCs (HPCs >15-fold, HSPCs > 30-fold) were 
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also achieved in the fDAS8/7 and fDAS8/10 cocultures (Fig. 5C, D), and these 
expansions were significantly higher than those in the fBM/14 coculture.  
     With respect to the cocultures with DAS 104-4 cells, similar to the cocultures 
with DAS 104-8 cells, the expansion of the HCs in the fDAS4/7 coculture was higher 
than in the DAS4/7 coculture (Fig. 5B, C). Compared with the fDAS8/7 coculture, 
expansion of HSPCs in fDAS4/7 was significantly lower (Fig. 5D), suggesting that 
DAS 104-8 cells are preferable to DAS 104-4 cells for expanding HSPCs in 3D 
cocultures.  
     From these results, it was clearly shown that 3D freezing of DAS 104-8 and 
DAS 104-4 cells strongly enhanced the expansion of primitive HCs in addition to B 
cells, whereas no beneficial effects of 3D freezing were observed in the cocultures 
with BMSCs.  
 
SEM observation 
Figure 6 shows representative SEM images of the 3D cocultured cells. When FLCs 
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were cocultured with BMSCs, both spherical cells that seemed to be HCs and 
flattened cells like stromal cells were observed (Fig. 6A, B). The flattened cells 
contacted with the spherical cells either by overlying (Fig. 6A) or surrounding (Fig. 
6B) a cluster of spherical cells on the 3D scaffolds. In the cocultures with DAS 104-8 
cells, a large amount of spindle-shaped cells covered the scaffold surfaces (Fig. 6C), 
and only a limited number of spherical cells existed on the surfaces (Fig. 6D). 
 
Discussion 
Umbilical cord blood cells have several advantages in HSC transplantation over 
BMCs; for example, they have a higher proportion of primitive HCs and are easier to 
harvest. By contrast, the small number of HSCs in each hUCB unit is a major 
obstacle to UCB transplantation into adult patients, so a several-fold expansion of 
HSCs in ex vivo cultures is expected to facilitate wider applicability of UCB 
transplantation [1,24]. To achieve ex vivo expansion of hUCB-derived HSCs, many 
investigations have been reported in which the in vivo hematopoietic 
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microenvironment was mimicked, e.g., cocultures with stromal cells [7,25], HSC 
cultures under hypoxic conditions [4,26], and cultures on acellular matrices [26]. 
These efforts have contributed to the sufficient expansion of primitive HCs dozens of 
times; however, exogenous cytokines such as stem cell factor (SCF) and 
thrombopoietin (TPO) were used to expand HCs in most of those cultures [1]. 
Because the added cytokines increase both the risks for inducing unwanted 
differentiation of HSPCs and the costs for clinical application, development of an 
effective expansion method without using exogenous cytokines is expected [27]. 
     In addition to the culture methods that mimic the hematopoietic 
microenvironment as described above, the importance of 3D architecture in 
expanding HSPCs has been recognized in recent years [28,29], and expansion of 
primitive HCs was achieved in 3D cultures using porous scaffolds constructed from 
biological products [11] and polymers [10,27,30]. Similarly to our previous studies 
[12-14,17], in the present study, a porous PVF scaffold was applied for the expansion 
of HCs to establish an effective method of expansion of primitive HCs that can be 
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applied to UCB transplantation. Instead of hUCB, mouse FLCs (ED 14) were used as 
a source of HCs, because the mouse fetal liver is a major hematopoietic organ after 
ED 11.5 and, similar to hUCB, contains more primitive HCs than does the bone 
marrow. As stromal cells, stromal cell lines were applied that were established from 
ED 11 mice and were close in origin to the FLCs. Consequently, more than 15-fold 
expansions of primitive HCs were achieved without addition of cytokines when the 
HCs were cocultured with 3D frozen-thawed stromal cell lines (Fig. 5). Although the 
details of the 3D culture conditions differed from those of previous reports, these 
expansion values seem to be comparable to those of previous reports and to be 
satisfactory for clinical application [24,26,27,30].  
     In the previous study using the same stromal cell lines, it was reported that 
DAS 104-4 was preferable to DAS 104-8 for expansion of primitive HCs without 
differentiation and that DAS 104-8 showed scarce ability to support the expansion 
[16]. These results were inconsistent with those obtained in this study (Fig. 5C, D), 
and the difference in culture conditions between these studies seems to be one of the 
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major causes for the inconsistency. In this study, FLCs were cocultured with the 
stromal cells instead of purified HSPCs that were applied in the previous report, and 
several types of cells included in the FLCs might affect the expansion of the primitive 
HCs. To examine the effects of HC sources on expansion of primitive HCs, 
expansion experiments of purified HSPCs using the present 3D cocultures will be 
needed. 
     With respect to the differences between 2D and 3D cultures, formation of cell 
aggregates in the 3D culture might have enhanced cell-cell interaction (Fig. 6), 
compared with the 2D culture. Cells cultured under 3D conditions are also known to 
exhibit activities different from those in 2D cultures [13,17-19,23]. Thus, it is 
plausible that the types and amount of surface markers expressed and of factors 
secreted by the stromal cell lines differed between the 2D and 3D cultures. 
Identification of these markers and factors will contribute to elucidation of the 
mechanism and the effective factors of HSC expansion. 
     Both the DAS 104-8 and the DAS 104-4 stromal cell lines used in this study 
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are CD34+ cells [16]; therefore, the possibility cannot be excluded that the remarkable 
increases in CD34+ cells in this study (Figs. 2-5) were caused by the proliferation of 
these stromal cell lines. However, this possibility seems to be negligible owing to the 
following facts: (1) The stromal cell lines showed poor proliferation after the 
processes of 3D freezing and thawing (data not shown), similar to the BMSCs used in 
our previous study [14]. (2) The cocultures with the stromal cell lines without 3D 
freezing resulted in considerably lower expansion of the CD34+ cells than of those 
with 3D freezing under all culture conditions (Fig. 5D), although the proliferating 
ability of the stromal cell lines without freezing should be higher than those with 3D 
freezing. Therefore, the high expansion of the CD34+ cells in the cocultures of HCs 
with DAS 104-8 or DAS 104-4 cells was almost certainly induced by that of 
primitive HCs.  
     With respect to the supportive mechanism of the stromal cells in HC expansion, 
several components might be involved, e.g., soluble factors secreted by the stromal 
cells, extracellular matrices accumulated around the stromal cells, and cell-cell 
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interactions between stromal cells and HCs [5,26]. In the present study, the 3D 
frozen-thawed stromal cell lines, in which the metabolic activities had probably 
deteriorated significantly as mentioned above, enhanced the expansion of HCs. These 
results strongly suggest that the soluble factors secreted by the stromal cell lines were 
not predominant in expanding the HCs when compared with the direct contact 
between the HCs and stromal cell lines or extracellular matrices in the 3D cultures 
[16,25]. Recently, it is increasingly recognized that stromal cells and differentiated 
HCs secrete a certain amount of factors that inhibit expansion of undifferentiated HCs 
[2,26], suggesting that decreased secretion of these inhibitory factors from the stromal 
cell lines caused by the damage from 3D freezing partly contributed to the high 
expansion of the primitive HCs.  
     In the present study, the effectiveness of 3D frozen-thawed stromal cells on 
HSC expansion was demonstrated by using AGM-region-derived stromal cell lines. 
Generally, growth of stromal cells is suppressed by gamma-irradiation or treatment 
with an inhibitor of DNA synthesis before the coculture with HCs for efficient 
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expansion of HCs [31-34]. Compared with other methods to suppress stromal cell 
growth, 3D freezing is very easy to perform and requires no special equipment or 
reagents. This method is also suited to treating large numbers of stromal cells. 
Therefore, 3D freezing is expected to be a novel means to treat stromal cells for the 
ex vivo expansion of primitive HCs.  
     To apply this method to expansion of hUCB-derived HSPCs clinically, 
selection of stromal cells suited to the expansion is needed [15]. Mouse and human 
stromal cells derived from the bone marrow, AGM region and fetal liver seem to be 
potential candidates [15], and the abilities of these stromal cells to expand 
hUCB-derived HSPCs should be compared under the 3D coculture conditions used in 
this study. In our preliminary study, bone marrow-derived stromal cell lines 
supported expansions of mouse HSPCs, similar to the cell lines derived from the 
AGM region shown in this study, and we plan to apply these stromal cells for 
expansion of HSPCs derived from hUCB. In addition to the selection of the stromal 
cells, detailed analysis of the expanded cells is also required. By using colony assay 
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and long-term bone marrow reconstitution activity by transplantation experiments of 
the expanded cells into lethally irradiated mice, the performances of expanded HCs 
should be evaluated accurately [12,16,18,35].  
     In conclusion, sufficient expansion of primitive HCs was achieved without 
addition of exogenous cytokines when the cells were cocultured with 3D 
frozen-thawed stromal cell lines. The coculture method is easy to perform, requires 
no special equipment or reagents, and offers a practical way to shorten the culture 
period for HC expansion. Therefore, this method is expected to be useful for 
expansion of HCs. 
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Figure legends 
Figure 1.  Growth of stromal cell lines in 3D cultures. Mean ± standard deviation 
(SD). Open circles, DAS 104-8 cells (n = 5); open squares, DAS 104-4 cells (n = 3). 
 
Figure 2.  Changes over time in the numbers of total cells and hematopoietic cells 
(HCs) after reinoculation in 3D coculture experiments of fetal liver cells (FLCs) with 
DAS 104-8 stromal cells. Mean ± SD. Open triangles, 3D coculture with DAS 104-8 
cells cultured for 3 days prior to the coculture (DAS8/3) (n = 4); open circles, 3D 
coculture with DAS 104-8 cells cultured for 7 days prior to the coculture (DAS8/7) (n 
= 3); open squares, 3D coculture with DAS 104-8 cells cultured for 10 days prior to 
the coculture (DAS8/10) (n = 3); open diamonds, 3D coculture with bone 
marrow-derived stromal cells (BMSCs) cultured for 14 days prior to the coculture 
(BM/14) (n = 3). Numbers of (A) total cells, (B) erythroid cells, (C) B cells, (D) 
hematopoietic progenitor cells (HPCs), and (E) hematopoietic stem/progenitor cells 
(HSPCs). *p < 0.05 vs. day 1; †p < 0.05 vs. DAS8/3. 
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Figure 3.  Changes over time in the numbers of total cells and HCs after 
reinoculation in 3D coculture experiments of FLCs with frozen-thawed DAS 104-8 
stromal cells. Mean ± SD. Closed circles, 3D coculture with frozen-thawed DAS 
104-8 cells cultured for 7 days prior to 3D freezing (fDAS8/7) (n = 3); closed squares, 
3D coculture with frozen-thawed DAS 104-8 cells cultured for 10 days prior to 3D 
freezing (fDAS8/10) (n = 3); closed diamonds, 3D coculture with frozen-thawed 
BMSCs cultured for 14 days prior to 3D freezing (fBM/14) (n = 3). Numbers of (A) 
total cells, (B) erythroid cells, (C) B cells, (D) HPCs, and (E) HSPCs. *p < 0.05 vs. 
day 1. 
 
Figure 4.  Changes over time in the numbers of total cells and HCs after 
reinoculation in 3D coculture experiments of FLCs with DAS 104-4 stromal cells 
with or without 3D freezing. Mean ± SD. Open circles, 3D coculture with DAS 104-4 
cells cultured for 7 days prior to the coculture (DAS4/7); closed circles, 3D coculture 
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with frozen-thawed DAS 104-4 cells cultured for 7 days prior to the 3D freezing 
(fDAS4/7). Numbers of (A) total cells (n = 4), (B) erythroid cells (n = 4), (C) B cells 
(n = 3), (D) HPCs (n = 3-4), and (E) HSPCs (n = 3-4). *p < 0.05 vs. day 1; #p < 0.05 
vs. cocultures without 3D freezing. 
 
Figure 5.  Expansions of HCs in 3D coculture experiments of FLCs with stromal 
cells with or without 3D freezing. Mean ± SD. Gray bars, 3D cocultures without 3D 
freezing (n = 3-4); closed bars, 3D cocultures with frozen-thawed stromal cells (n = 
3-4). Expansions of (A) erythroid cells, (B) B cells, (C) HPCs, and (D) HSPCs. #p < 
0.05 vs. cocultures without 3D freezing; **p < 0.05 vs. cocultures with BMSCs 
(BM/14 or fBM/14); ***p < 0.05 vs. DAS 104-8 cells (DAS8/7 or fDAS8/7). ND, 
not done.   
 
Figure 6.  Scanning electron micrographs of FLCs cocultured with stromal cells 
within 3D scaffolds. (A) FLCs cocultured with frozen-thawed BMSCs (fBM/14, day 
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14). Bar = 100 µm. (B) Cluster of spherical cells surrounded by flattened cells 
(fBM/14, day 14). Bar = 10 µm. (C) FLCs cocultured with DAS 104-8 stromal cells 
(DAS8/7, day 14). Bar = 100 µm. (D) Higher magnification of Figure 6C. Bar = 10 
µm. *PVF scaffold; arrow: flattened cells overlying a cluster of spherical cells. 
 
Table 1.  Conditions of stromal cell cultures prior to the cocultures for expanding 
hematopoietic cells. 
Culture condition Stromal cell Culture medium Duration of stromal 
cell culture [days] 
3D freezing 
DAS8/3 DAS 104-8 HAVA medium 3 - 
DAS8/7 DAS 104-8 HAVA medium 7 - 
DAS8/10 DAS 104-8 HAVA medium 10 - 
fDAS8/7 DAS 104-8 HAVA medium 7 + 
fDAS8/10 DAS 104-8 HAVA medium 10 + 
     
DAS4/7 DAS 104-4 HAVA medium 7 - 
fDAS4/7 DAS 104-4 HAVA medium 7 + 
     
BM/14 BMSCs MEM 14 - 
fBM/14 BMSCs MEM 14 + 
 
 
Table 1
Table 2.  Percentages of Ter119
+
 erythroid cells, B220
+
 B cells, c-kit
+
 hematopoietic 
progenitor cells (HPCs), and CD34
+
 hematopoietic stem/progenitor cells (HSPCs) in 3D 
cocultures with DAS 104-8 stromal cells or bone marrow-derived stromal cells (BMSCs). 
Marker 
Culture 
condition 
% of positive cells  
Marker 
Culture 
condition 
% of positive cells 
Day 1 Day 14 Day 1 Day 14 
Ter119 DAS8/3 87.0 ± 1.6 18.7 ± 10.8
*,**
  B220 DAS8/3 3.6 ± 0.5 6.3 ± 4.1
**
 
 DAS8/7 79.2 ± 6.9 21.1 ± 5.9
*,**
   DAS8/7 6.8 ± 4.6 8.5 ± 3.9
**
 
 DAS8/10 76.6 ± 14.1 25.1 ± 10.3
*
   DAS8/10 3.1 ± 1.4 10.4 ± 1.5
*,**
 
 BM/14 84.5 ± 4.9 41.8 ± 5.9
*
   BM/14 3.5 ± 2.9 17.6 ± 2.0
*
 
         
c-kit DAS8/3 4.6 ± 2.4
**
 22.7 ± 12.2
*
  CD34 DAS8/3 4.4 ± 1.3 27.3 ± 11.8
*
 
 DAS8/7 10.6 ± 5.5 33.5 ± 13.3   DAS8/7 9.7 ± 2.7
†,**
 40.3 ± 16.0
*
 
 DAS8/10 7.4 ± 6.1 35.1 ± 16.6   DAS8/10 6.2 ± 4.9 36.7 ± 11.3
*
 
 BM/14 9.0 ± 1.9 21.3 ± 1.7
*
   BM/14 3.1 ± 1.6 22.0 ± 15.9 
The number of experiments is the same as in Figure 2.   
*p < 0.05 vs. day 1; 
†
p < 0.05 vs. DAS8/3; **p < 0.05 vs. BM/14.   
 
Table 2
Table 3.  Percentages of Ter119
+
 erythroid cells, B220
+
 B cells, c-kit
+
 HPCs, and CD34
+
 
HSPCs in 3D cocultures with frozen-thawed DAS 104-8 stromal cells or frozen-thawed 
BMSCs.  
Marker 
Culture 
condition 
% of positive cells  
Marker 
Culture 
condition 
% of positive cells 
Day 1 Day 14 Day 1 Day 14 
Ter119 fDAS8/7 90.7 ± 2.2
**
 21.0 ± 8.1
*
  B220 fDAS8/7 1.8 ± 0.5 11.7 ± 6.6 
 fDAS8/10 88.3 ± 1.9
**
 22.6 ± 5.8
*
   fDAS8/10 1.1 ± 0.4 10.6 ± 1.0
*
 
 fBM/14 78.9 ± 4.2 28.8 ± 7.9
*
   fBM/14 3.4 ± 2.2 20.7 ± 10.7 
         
c-kit fDAS8/7 3.4 ± 0.9
**
 34.5 ± 16.9
*
  CD34 fDAS8/7 2.2 ± 0.4 41.8 ± 7.9
*,**
 
 fDAS8/10 3.0 ± 0.8
**
 29.1 ± 3.7
*,**
   fDAS8/10 1.7 ± 0.7 42.6 ± 10.9
*,**
 
 fBM/14 10.5 ± 2.8 13.6 ± 7.2   fBM/14 4.6 ± 1.8 16.9 ± 9.6 
The number of experiments is the same as in Figure 3.   
*p < 0.05 vs. day 1; **p < 0.05 vs. fBM/14.   
 
Table 3
Table 4.  Percentages of Ter119
+
 erythroid cells, B220
+
 B cells, c-kit
+
 HPCs, and CD34
+
 
HSPCs in 3D cocultures with DAS 104-4 stromal cells with or without 3D freezing.  
Marker 
Culture 
condition 
% of positive cells  
Marker 
Culture 
condition 
% of positive cells 
Day 1 Day 14 Day 1 Day 14 
Ter119 DAS4/7 26.3 ± 9.0
**,***
 21.4 ± 12.5
**
  B220 DAS4/7 8.0 ± 0.5 4.0 ± 3.4
**
 
 fDAS4/7 29.5 ± 5.6
**,***
 25.8 ± 5.5   fDAS4/7 3.3 ± 1.4 9.1 ± 5.5 
         
c-kit DAS4/7 2.1 ± 0.9
**,***
 9.7 ± 7.9
***
  CD34 DAS4/7 5.9 ± 3.5 9.9 ± 6.9
***
 
 fDAS4/7 1.2 ± 0.4
**,***
 25.2 ± 2.9
*,**
   fDAS4/7 4.0 ± 0.5
***
 14.1 ± 6.2
*,***
 
The number of experiments is the same as in Figure 4.   
*p < 0.05 vs. day 1; **p < 0.05 vs. cocultures with BMSCs (BM/14 or fBM/14); ***p < 0.05 
vs. cocultures with DAS 104-8 cells (DAS8/7 or fDAS8/7). 
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